Further, a study found almost no correlation between increasing lipophilicity of triptans and their therapeutic gain, while the authors noted an almost significant correlation between increasing lipophilicity and CNS adverse events [ 50 ].
← all excerpts
Lasmiditan and 5-Hydroxytryptamine in the rat trigeminal system; expression, release and interactions with 5-HT<sub>1</sub> receptors.
1
—
—